Published ahead of print on May 30, 2003, doi:10.1165/rcmb.2003-0028OC
Am. J. Respir. Cell Mol. Biol., Volume 29, Number 5, November 2003, 571-582
A more recent version of this article appeared on November 1, 2003
Submitted on January 27, 2003
Revised on May 14, 2003
Human ADAM33 mRNA expression profile and post- transcriptional regulation
Shelby P Umland1*, Charles G Garlisi1, Himanshu Shah1, Yuntao Wan1, Jun Zou1, Kristine E Devito1, Whei-Mei Huang2, Eric L Gustafson3, and Robert Ralston2
1 Allergy, Schering Plough Research Institute, Kenilworth, NJ, USA,
2 Canji Inc., San Diego, CA, USA,
3 Human Genomics, Schering Plough Research Institute, Kenilworth, NJ, USA
* To whom correspondence should be addressed. E-mail: shelby.umland{at}spcorp.com.
We examined transcript expression and post-transcriptional regulation of human ADAM33, a recently identified asthma gene. A detailed mRNA expression profile was obtained using Northern, RT-PCR and ISH analyses. ADAM33 mRNA was expressed significantly in smooth muscle-containing organs, minimally in immune organs and hematopoietic cells and highly in repairing duodenal granulation tissue. Expression was seen in asthmatic subepithelial fibroblasts and smooth muscle but not in respiratory epithelium. In all tissues, transcripts of ~ 5 kb predominated over those of ~3.5 kb by 2- to 5-fold. The effect of the 3'UTR on ADAM33 protein expression and maturation was examined. The presence of the 3'UTR in untagged full-length constructs promoted prodomain removal, detected as mature ~100 kD protein by ADAM33-reactive antibodies; in its absence, maturation was 2- to 3-fold less in HEK293 cells. His-tagged and untagged constructs lacking the 3'UTR demonstrated that lack of maturation was not via tag-mediated effects. Minimal maturation of ADAM33 occurred in primary lung and MRC5 fibroblasts following adenoviral-mediated expression of ADAM33 lacking the 3'UTR. In contrast, prodomain removal was observed with plasmids and adenovirus encoding only the pro- and catalytic domains. Thus, the 3'UTR of ADAM33 and domains downstream of the catalytic regulate potential ADAM33 activity. Mechanisms of regulation of ADAM33, distinct from closely related ADAMs, thus include mRNA localization and processing and protein maturation.
This article has been cited by other articles:

|
 |

|
 |
 
F. Sampsonas, A. Kaparianos, D. Lykouras, K. Karkoulias, and K. Spiropoulos
DNA sequence variations of metalloproteinases: their role in asthma and COPD
Postgrad. Med. J.,
April 1, 2007;
83(978):
244 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M E Gosman, H Marike Boezen, C. C van Diemen, J. B Snoeck-Stroband, T. S Lapperre, P. S Hiemstra, N. H T ten Hacken, J. Stolk, D. S Postma, and the GLUCOLD Study Group
A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology
Thorax,
March 1, 2007;
62(3):
242 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Lee, S.-W. Park, H. K. Chang, H. Y. Kim, T. Rhim, J.-H. Lee, A.-S. Jang, E.-S. Koh, and C.-S. Park
A Disintegrin and Metalloproteinase 33 Protein in Patients with Asthma: Relevance to Airflow Limitation
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
729 - 735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. van Diemen, D. S. Postma, J. M. Vonk, M. Bruinenberg, J. P. Schouten, and H. M. Boezen
A Disintegrin and Metalloprotease 33 Polymorphisms and Lung Function Decline in the General Population
Am. J. Respir. Crit. Care Med.,
August 1, 2005;
172(3):
329 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Simpson, N. Maniatis, F. Jury, J. A. Cakebread, L. A. Lowe, S. T. Holgate, A. Woodcock, W. E. R. Ollier, A. Collins, A. Custovic, et al.
Polymorphisms in A Disintegrin and Metalloprotease 33 (ADAM33) Predict Impaired Early-Life Lung Function
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
55 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Haitchi, R. M. Powell, T. J. Shaw, P. H. Howarth, S. J. Wilson, D. I. Wilson, S. T. Holgate, and D. E. Davies
ADAM33 Expression in Asthmatic Airways and Human Embryonic Lungs
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
958 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S T Holgate and J W Holloway
Is big beautiful? The continuing story of ADAM33 and asthma
Thorax,
April 1, 2005;
60(4):
263 - 264.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Blakey, E Halapi, U S Bjornsdottir, A Wheatley, S Kristinsson, R Upmanyu, K Stefansson, H Hakonarson, and I P Hall
Contribution of ADAM33 polymorphisms to the population risk of asthma
Thorax,
April 1, 2005;
60(4):
274 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Raby and S. T. Weiss
ADAM33: Where Are We Now?
Am. J. Respir. Cell Mol. Biol.,
July 1, 2004;
31(1):
1 - 2.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Powell, J. Wicks, J. W. Holloway, S. T. Holgate, and D. E. Davies
The Splicing and Fate of ADAM33 Transcripts in Primary Human Airways Fibroblasts
Am. J. Respir. Cell Mol. Biol.,
July 1, 2004;
31(1):
13 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.T. Holgate
Lessons learnt from the epidemic of asthma
QJM,
May 1, 2004;
97(5):
247 - 257.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zou, F. Zhu, J. Liu, W. Wang, R. Zhang, C. G. Garlisi, Y.-H. Liu, S. Wang, H. Shah, Y. Wan, et al.
Catalytic Activity of Human ADAM33
J. Biol. Chem.,
March 12, 2004;
279(11):
9818 - 9830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T Holgate
The epidemic of asthma and allergy
J R Soc Med,
March 1, 2004;
97(3):
103 - 110.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|